SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001628280-24-046316
Filing Date
2024-11-07
Accepted
2024-11-07 16:26:24
Documents
54
Period of Report
2024-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q rgls-20240930.htm   iXBRL 10-Q 1313101
2 EX-31.1 ex-311x20240930.htm EX-31.1 9694
3 EX-31.2 ex-312x20240930.htm EX-31.2 9685
4 EX-32.1 ex-321x20240930.htm EX-32.1 9556
  Complete submission text file 0001628280-24-046316.txt   5521976

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT rgls-20240930.xsd EX-101.SCH 30919
6 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT rgls-20240930_cal.xml EX-101.CAL 51949
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT rgls-20240930_def.xml EX-101.DEF 197056
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT rgls-20240930_lab.xml EX-101.LAB 526769
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT rgls-20240930_pre.xml EX-101.PRE 344622
56 EXTRACTED XBRL INSTANCE DOCUMENT rgls-20240930_htm.xml XML 571466
Mailing Address 4224 CAMPUS POINT COURT SUITE 210 SAN DIEGO CA 92121
Business Address 4224 CAMPUS POINT COURT SUITE 210 SAN DIEGO CA 92121 858-202-6300
Regulus Therapeutics Inc. (Filer) CIK: 0001505512 (see all company filings)

IRS No.: 264738379 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-35670 | Film No.: 241436254
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)